MAM
ABBV icon

Morse Asset Management’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.3M Sell
6,998
-150
-2% -$27.8K 0.28% 78
2025
Q1
$1.5M Sell
7,148
-165
-2% -$34.6K 0.38% 63
2024
Q4
$1.3M Sell
7,313
-250
-3% -$44.4K 0.3% 74
2024
Q3
$1.49M Buy
7,563
+175
+2% +$34.6K 0.32% 72
2024
Q2
$1.27M Sell
7,388
-500
-6% -$85.7K 0.31% 72
2024
Q1
$1.44M Sell
7,888
-2
-0% -$364 0.37% 66
2023
Q4
$1.22M Sell
7,890
-1,010
-11% -$157K 0.36% 67
2023
Q3
$1.33M Sell
8,900
-13,806
-61% -$2.06M 0.42% 64
2023
Q2
$3.06M Sell
22,706
-34,353
-60% -$4.63M 0.93% 38
2023
Q1
$9.09M Sell
57,059
-1,280
-2% -$204K 3.07% 4
2022
Q4
$9.43M Sell
58,339
-437
-0.7% -$70.6K 3.42% 3
2022
Q3
$7.89M Sell
58,776
-240
-0.4% -$32.2K 2.98% 6
2022
Q2
$9.04M Buy
59,016
+2,190
+4% +$335K 2.9% 7
2022
Q1
$9.21M Sell
56,826
-2,625
-4% -$426K 2.29% 7
2021
Q4
$8.05M Buy
59,451
+625
+1% +$84.6K 1.8% 14
2021
Q3
$6.35M Sell
58,826
-2,473
-4% -$267K 1.51% 16
2021
Q2
$6.91M Sell
61,299
-1,270
-2% -$143K 1.67% 14
2021
Q1
$6.77M Buy
62,569
+5,085
+9% +$550K 1.74% 15
2020
Q4
$6.16M Buy
57,484
+6,645
+13% +$712K 1.71% 15
2020
Q3
$4.45M Sell
50,839
-420
-0.8% -$36.8K 1.43% 18
2020
Q2
$5.03M Buy
51,259
+8,454
+20% +$830K 1.79% 17
2020
Q1
$3.26M Buy
42,805
+4,000
+10% +$305K 1.56% 18
2019
Q4
$3.44M Buy
38,805
+27,055
+230% +$2.4M 1.18% 25
2019
Q3
$890K Hold
11,750
0.33% 70
2019
Q2
$854K Sell
11,750
-200
-2% -$14.5K 0.25% 83
2019
Q1
$963K Sell
11,950
-15,535
-57% -$1.25M 0.29% 73
2018
Q4
$2.53M Sell
27,485
-2,680
-9% -$247K 0.9% 35
2018
Q3
$2.85M Sell
30,165
-19,795
-40% -$1.87M 0.75% 43
2018
Q2
$4.63M Sell
49,960
-13,200
-21% -$1.22M 1.27% 24
2018
Q1
$5.98M Buy
63,160
+615
+1% +$58.2K 1.66% 15
2017
Q4
$6.05M Buy
62,545
+1,035
+2% +$100K 1.68% 17
2017
Q3
$5.47M Buy
61,510
+8,120
+15% +$722K 1.63% 16
2017
Q2
$3.87M Buy
53,390
+14,785
+38% +$1.07M 1.26% 26
2017
Q1
$2.52M Buy
+38,605
New +$2.52M 0.86% 40